BioAura LabsResearch Vials
PEPTIDE BLENDS BIOAURA LABS
Wolverine Blend
A two-component blend for comparative peptide studies.
Wolverine Blend is BioAura’s listed BPC-157 + TB-500 combination in a 20 mg presentation. Research evaluation begins with identifying both constituents and their respective amounts.
For laboratory research use only.
Not for human or veterinary use.
20 mg · Vials
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
A two-component blend for comparative peptide studies.
BPC-157 and TB-500 are discussed in peptide signaling and cellular-response research. A combined preparation is a separate research material: information about each ingredient does not by itself demonstrate how the finished mixture behaves.
Comparisons should account for the TB-500 sequence designation, component ratio, analytical separation, and content of each constituent. The supplied list does not specify a 10 mg/10 mg split, and no enhanced or synergistic effect is claimed.
RESEARCH CONTEXT
Comparative peptide-signaling research
Blend compatibility and degradation assessment
Specifications
- Catalog identity
- Wolverine Blend
- Research classification
- Research peptide blend · BPC-157/TB-500
- Available presentations
- 20 mg · Vials
- Intended use
- For laboratory research use only. Not for human or veterinary use. Not for consumption or administration.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- BPC-157 amount, exact TB-500 identity and amount, blend ratio, component-specific assay, and lot documentation.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
BPC-157 amount, exact TB-500 identity and amount, blend ratio, component-specific assay, and lot documentation.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
Does 20 mg mean 10 mg of each component?
Not necessarily. Only the total presentation was supplied. The component split must be verified against the supplier specification.
What does the listed presentation tell me?
20 mg · Vials. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is this intended for human or veterinary use?
For laboratory research use only. Not for human or veterinary use. Not for consumption or administration. This page provides no treatment, dosing, reconstitution, or administration guidance.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING